×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ICCC – immucell corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ICCC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
07:03 pm
iccc
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth [Yahoo! Finance]
Low
Report
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth [Yahoo! Finance]
11/26
02:09 pm
iccc
ImmuCell (NASDAQ:ICCC) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
ImmuCell (NASDAQ:ICCC) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
11/14
11:08 am
iccc
ImmuCell signals operational excellence and targets $30M annual production capacity amid management transition [Seeking Alpha]
Low
Report
ImmuCell signals operational excellence and targets $30M annual production capacity amid management transition [Seeking Alpha]
11/14
11:02 am
iccc
ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/6
04:05 pm
iccc
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
Low
Report
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
11/4
04:05 pm
iccc
ImmuCell Announces Onboarding of New CEO and Related Management Changes
Medium
Report
ImmuCell Announces Onboarding of New CEO and Related Management Changes
11/1
09:38 am
iccc
Is ImmuCell Corporation's (NASDAQ:ICCC) Recent Price Movement Underpinned By Its Weak Fundamentals? [Yahoo! Finance]
Low
Report
Is ImmuCell Corporation's (NASDAQ:ICCC) Recent Price Movement Underpinned By Its Weak Fundamentals? [Yahoo! Finance]
10/8
12:25 pm
iccc
ImmuCell (NASDAQ:ICCC) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
ImmuCell (NASDAQ:ICCC) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/4
04:12 pm
iccc
Form 4/A IMMUCELL CORP /DE/ For: Dec 03 Filed by: te Boekhorst Paul Francis Olivier
Medium
Report
Form 4/A IMMUCELL CORP /DE/ For: Dec 03 Filed by: te Boekhorst Paul Francis Olivier
12/3
04:14 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Dec 02 Filed by: te Boekhorst Paul Francis Olivier
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Dec 02 Filed by: te Boekhorst Paul Francis Olivier
11/28
08:13 am
iccc
Form 4 IMMUCELL CORP /DE/ For: Nov 25 Filed by: Tomsche David Scott
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Nov 25 Filed by: Tomsche David Scott
11/20
04:36 pm
iccc
Form SCHEDULE 13D/A IMMUCELL CORP /DE/ Filed by: Knudsen Ejnar A III
Low
Report
Form SCHEDULE 13D/A IMMUCELL CORP /DE/ Filed by: Knudsen Ejnar A III
11/12
08:43 am
iccc
Form 4 IMMUCELL CORP /DE/ For: Nov 07 Filed by: te Boekhorst Paul Francis Olivier
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Nov 07 Filed by: te Boekhorst Paul Francis Olivier
11/7
07:41 am
iccc
Form 3 IMMUCELL CORP /DE/ For: Oct 29 Filed by: te Boekhorst Paul Francis Olivier
Medium
Report
Form 3 IMMUCELL CORP /DE/ For: Oct 29 Filed by: te Boekhorst Paul Francis Olivier
11/4
04:09 pm
iccc
Form 8-K IMMUCELL CORP /DE/ For: Oct 29
Medium
Report
Form 8-K IMMUCELL CORP /DE/ For: Oct 29
10/7
04:06 pm
iccc
Form 8-K IMMUCELL CORP /DE/ For: Oct 07
Low
Report
Form 8-K IMMUCELL CORP /DE/ For: Oct 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/21
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
6.9%
5/7 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 5.8%
4/2 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 3.5%
2/19 ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.5%
8/6 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 2.6%
2/13 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 2.4%
4/14 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program 2.0%
9/11 ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™ 1.9%
4/28 Form DEF 14A IMMUCELL CORP /DE/ For: Jun 10 1.5%
1/22 Form 8-K IMMUCELL CORP /DE/ For: Jan 21 1.2%
5/7 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 5.8%
4/2 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 3.5%
2/19 ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.5%
8/6 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 2.6%
2/13 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 2.4%
4/14 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program 2.0%
9/11 ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™ 1.9%
4/28 Form DEF 14A IMMUCELL CORP /DE/ For: Jun 10 1.5%
1/22 Form 8-K IMMUCELL CORP /DE/ For: Jan 21 1.2%
TOP News Decliners
3/2
Form 4 IMMUCELL CORP /DE/ For: Feb 27 Filed by: Tomsche David Scott
-10.1%
2/18 Form 8-K IMMUCELL CORP /DE/ For: Feb 18 -8.5%
3/11 ImmuCell Announces Refinancing of its Bank Debt -7.4%
5/10 Form DEFR14A IMMUCELL CORP /DE/ -3.3%
9/11 Form 8-K IMMUCELL CORP /DE/ For: Sep 05 -3.3%
9/5 ImmuCell Co. (NASDAQ: ICCC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.2%
3/27 Form S-8 IMMUCELL CORP /DE/ -3.0%
5/14 ImmuCell Corporation's (ICCC) CEO Michael Brigham on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.0%
12/12 Form 4 IMMUCELL CORP /DE/ For: Dec 09 Filed by: Brockmann Bobbi Jo -1.8%
1/28 Form SC 13G IMMUCELL CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP -1.6%
2/18 Form 8-K IMMUCELL CORP /DE/ For: Feb 18 -8.5%
3/11 ImmuCell Announces Refinancing of its Bank Debt -7.4%
5/10 Form DEFR14A IMMUCELL CORP /DE/ -3.3%
9/11 Form 8-K IMMUCELL CORP /DE/ For: Sep 05 -3.3%
9/5 ImmuCell Co. (NASDAQ: ICCC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.2%
3/27 Form S-8 IMMUCELL CORP /DE/ -3.0%
5/14 ImmuCell Corporation's (ICCC) CEO Michael Brigham on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.0%
12/12 Form 4 IMMUCELL CORP /DE/ For: Dec 09 Filed by: Brockmann Bobbi Jo -1.8%
1/28 Form SC 13G IMMUCELL CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: